Noida, India (PressExposure) March 08, 2011 -- According to our recent research report "US Diagnostic Market Outlook 2014", the US IVD industry is already in a pivotal position to secure a significant share in the healthcare industry. The main reasons for bright prospects are prevalence of several chronic and infectious diseases, emergence of technologies in hospital laboratories, and increasing patient awareness among others. The US is currently at the forefront of diagnostic market development globally. The report further revealed that the industry would orchestrate 9.7% CAGR growth during 2011-2014. High growth forecasts confirm US diagnostic market's attractiveness for future investments.
The study identified that the US constitutes the largest and the most advanced diagnostic market in the world. Investments worth billions of dollars are being made in research and development of various market segments including, POC, clinical chemistry, immuno-assay molecular diagnostic techniques both by public and private organizations. We anticipate this trend to remain applicable during our forecast period also owing to various supporting factors and strong market fundamentals as discussed and analyzed in the report.
Further, the US IVD market is highly regulated and the top-ten IVD manufacturers presently control about 80% of the industry sales. However, companies do not compete in every market segment and thus, market is well poised to witness entry of new players and expansion of existing ones. Further, despite the US recognition as the most advanced market, the competition level in various products/therapeutic categories is still not stiff and considerable business opportunities are available for market players.
Our report "US Diagnostic Market Outlook 2014" has been authored to evaluate the US diagnostic market potentials and identify future growth opportunities. The report provides extensive research and analysis on current market trends and future forecasts on all prominent diagnostic techniques including POCT, clinical chemistry, immunoassays, blood testing, and molecular diagnostics. Further, the report facilitates information/statistics on market developments in laboratory applications and disease indications. Projections made on market future scenario will help clients to take informed and proactive business decisions in the fast growing US diagnostic market.
For FREE SAMPLE of this report visit: [http://www.rncos.com/Report/IM298.htm]
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm